ETFs positioned on L&C Bio Co., Ltd

Name Weight AuM 1st Jan change Investor Rating
0.01% 4 M€ -4.41% -
L&C BIO Co., Ltd is a Korea-based Company mainly engaged in the regenerative medicine business. The Company mainly manufactures and sells human tissue transplant materials used for tissue repair and filler. The Company also produces and sells human tissue-based medical devices and Cosmeceuticals. Its products are used in vascular surgeries, plastic surgeries, general surgeries and others.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A290650 Stock
  4. Funds and ETFs L&C Bio Co., Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW